The Indian parliament on Tuesday approved a controversial bill that prevents domestic companies copying branded drugs after the government overcame opposition from left-wing allies by accepting amendments to curb potential abuses by multinationals.

India is required to put into effect a patent law under the country's obligations to the World Trade Organisation, but critics had claimed the original text was too tough and failed to take advantage of flexibility in the WTO system permitting governments to promote "access to medicines for all".